HALO logo
halo search icon
Agenus Inc.

US$3.15

Price Change Indicator
0.06 (1.94%)
Agenus Inc.
AGEN · NAS

Agenus Inc.

Start Trading AGEN for Free

US$3.15

Price Arrow0.06 (1.94%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusBig CandleHALO AllHALO Consensus ValueHALO Value
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Agenus Inc. Overview

AGEN Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Very Weak

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About AGEN

icon
icon

Telephone

1.781.674.4400

icon

Address

3 Forbes Road, Lexington, MA 02421-7305

Description

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

AGEN Price Chart

Key Stats

Market Cap

US$128.68M

PE

8.80

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 2.71 - 7.34

Trade Value (12mth)

US$870,481.00

1 week

-13.69%

1 month

-20.97%

YTD

-4.33%

1 year

-15.57%

All time high

1884.11

Key Fundamentals

EPS 3 yr Growth

-100.00%

EBITDA Margin

-9.20%

Operating Cashflow

-$77m

Free Cash Flow Return

0.00%

ROIC

0.00%

Interest Coverage

-0.20

Quick Ratio

0.40

Other Data

Shares Outstanding (Fully Diluted)

38m

HALO Sector

Healthcare

Next Company Report Date

16-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

AGEN Announcements

Latest Announcements

DateAnnouncements
16 May 26
16 May 26
16 May 26
12 May 26
12 May 26

AGEN Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-13.75-10.59N/Alocklocklock
EPS (Fully Diluted)
 $locklocklocklock-13.75-10.59N/Alocklocklock
Growth
 %locklocklocklock12.122.9100locklocklock
PE
 XlocklocklocklockN/AN/A8.8locklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Agenus Inc. (AGEN:NAS)?
Halo FAQ
The current share price of Agenus Inc. (AGEN:NAS) is USD$3.15.
What is the 52-week high share price for Agenus Inc. (AGEN:NAS)?
Halo FAQ
The 52-week high share price for Agenus Inc. (AGEN:NAS) is USD$7.34.
What is the 52-week low share price for Agenus Inc. (AGEN:NAS)?
Halo FAQ
The 52-week low share price for Agenus Inc. (AGEN:NAS) is USD$2.71.
What is the dividend yield for Agenus Inc. (AGEN:NAS)?
Halo FAQ
Agenus Inc. (AGEN:NAS) does not pay a dividend.
What was Agenus Inc. (AGEN:NAS) last dividend payment?
Halo FAQ
Agenus Inc. (AGEN:NAS) does not pay a dividend.
What is the franking level for Agenus Inc. (AGEN:NAS)?
Halo FAQ
Agenus Inc. (AGEN:NAS) has a franking level of 0.00%.
In which sector is Agenus Inc. (AGEN:NAS) classified?
Halo FAQ
Agenus Inc. (AGEN:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Agenus Inc. (AGEN:NAS)?
Halo FAQ
The current P/E ratio for Agenus Inc. (AGEN:NAS) is 8.80.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial